Xilio Therapeutics, Inc. (Nasdaq:XLO)

Health Care/Life Sciences • Biotechnology

CIK 1840233

Company

Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer. The company uses its proprietary geographically precise solutions platform to rapidly engineer novel molecules, including cytokines and other biologics. Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.

Address
828 Winter Street
Suite 300
Waltham, Massachusetts 02451

Employees
73

Stock Info

Close
$0.9094

Day Range
0.8500 - 0.9339

52 Week Range
0.5800 - 1.9300

Average volume
3.79M

Short Interest
1.81M (02/14/25)

% of Float Shorted
9.52%

Market Cap
$41.61M

Revenue
N/A

Net Income
-$76.4M

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$1.7190

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Director
James Samuel Shannon

Director
Aoife M. Brennan

Independent Director
Christina Rossi

Independent Director
Robert W. Ross

Independent Director
Daniel Curran

Independent Director
Sara M. Bonstein

Independent Director
Yuan J. Xu

SEC filings

Date	Form	Event
19 Dec, 2024	SCHEDULE 1
19 Dec, 2024	8-K
19 Dec, 2024	4
14 Nov, 2024	SC 13G/A
14 Nov, 2024	SC 13G/A
12 Nov, 2024	SC 13G/A
12 Nov, 2024	SC 13G/A
7 Nov, 2024	8-K
7 Nov, 2024	10-Q
2 Oct, 2024	4
27 Sep, 2024	3
27 Sep, 2024	SC 13G
13 Sep, 2024	8-K
8 Aug, 2024	8-K
8 Aug, 2024	10-Q
6 Aug, 2024	4
31 Jul, 2024	SC 13G/A
17 Jun, 2024	4
17 Jun, 2024	4
17 Jun, 2024	4
17 Jun, 2024	8-K
17 Jun, 2024	4
17 Jun, 2024	4
17 Jun, 2024	4
17 Jun, 2024	4
17 Jun, 2024	4
17 Jun, 2024	3
17 Jun, 2024	3
13 Jun, 2024	8-K
14 May, 2024	8-K
14 May, 2024	10-Q
6 May, 2024	EFFECT
3 May, 2024	4
3 May, 2024	4
3 May, 2024	4
3 May, 2024	4
2 May, 2024	CORRESP
2 May, 2024	UPLOAD
30 Apr, 2024	S-3
25 Apr, 2024	ARS
25 Apr, 2024	DEFA14A
25 Apr, 2024	DEF 14A
15 Apr, 2024	424B5
5 Apr, 2024	SC 13G/A
5 Apr, 2024	SC 13G
3 Apr, 2024	4
3 Apr, 2024	3
1 Apr, 2024	8-K
1 Apr, 2024	10-K
1 Apr, 2024	S-8
28 Mar, 2024	8-K
28 Mar, 2024	8-K
14 Feb, 2024	SC 13G
9 Feb, 2024	4
6 Feb, 2024	SC 13G/A
5 Feb, 2024	SC 13G/A
16 Jan, 2024	4
3 Jan, 2024	4
3 Jan, 2024	4
3 Jan, 2024	8-K
3 Jan, 2024	4
3 Jan, 2024	4
7 Dec, 2023	8-K
9 Nov, 2023	8-K
9 Nov, 2023	10-Q/A
9 Nov, 2023	10-K/A
9 Nov, 2023	10-Q/A
9 Nov, 2023	10-Q
3 Nov, 2023	8-K
7 Sep, 2023	4
7 Sep, 2023	3
5 Sep, 2023	8-K	CEO Change
18 Aug, 2023	4
18 Aug, 2023	4
18 Aug, 2023	4
18 Aug, 2023	4
14 Aug, 2023	8-K
14 Aug, 2023	10-Q
7 Aug, 2023	4
7 Aug, 2023	3
3 Aug, 2023	8-K
13 Jun, 2023	4
13 Jun, 2023	4
13 Jun, 2023	4
13 Jun, 2023	4
13 Jun, 2023	4
13 Jun, 2023	4
13 Jun, 2023	8-K
25 May, 2023	8-K
9 May, 2023	10-Q
9 May, 2023	8-K
25 Apr, 2023	DEFA14A
25 Apr, 2023	DEF 14A
25 Apr, 2023	ARS
10 Apr, 2023	SC 13G
3 Apr, 2023	4
3 Apr, 2023	3
3 Apr, 2023	8-K
2 Mar, 2023	8-K
2 Mar, 2023	S-8
2 Mar, 2023	10-K
9 Feb, 2023	SC 13G/A
25 Jan, 2023	SC 13G
9 Jan, 2023	8-K
4 Jan, 2023	4
4 Jan, 2023	4
4 Jan, 2023	4
29 Dec, 2022	SC 13G/A
23 Dec, 2022	8-K
18 Nov, 2022	EFFECT
16 Nov, 2022	3
16 Nov, 2022	CORRESP
15 Nov, 2022	UPLOAD
14 Nov, 2022	SC 13G/A
9 Nov, 2022	10-Q
9 Nov, 2022	8-K
9 Nov, 2022	S-3
16 Sep, 2022	3
16 Sep, 2022	4
15 Sep, 2022	8-K
9 Aug, 2022	8-K
9 Aug, 2022	10-Q
28 Jul, 2022	8-K
23 Jun, 2022	4/A
17 Jun, 2022	4
17 Jun, 2022	3
17 Jun, 2022	4
17 Jun, 2022	4
17 Jun, 2022	4
17 Jun, 2022	4
17 Jun, 2022	4
17 Jun, 2022	4
16 Jun, 2022	8-K
13 Jun, 2022	8-K
12 May, 2022	8-K
12 May, 2022	10-Q
26 Apr, 2022	DEFA14A
26 Apr, 2022	DEF 14A
1 Mar, 2022	10-K
1 Mar, 2022	S-8
1 Mar, 2022	8-K
24 Feb, 2022	4
24 Feb, 2022	4
24 Feb, 2022	4
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
11 Feb, 2022	SC 13G/A
9 Feb, 2022	SC 13G/A
4 Feb, 2022	8-K
14 Jan, 2022	SC 13G
6 Jan, 2022	8-K
6 Jan, 2022	4
6 Jan, 2022	3
4 Jan, 2022	4/A
23 Dec, 2021	4
10 Dec, 2021	4
2 Dec, 2021	8-K
2 Dec, 2021	10-Q
5 Nov, 2021	SC 13D
5 Nov, 2021	SC 13G
5 Nov, 2021	SC 13G
5 Nov, 2021	SC 13G
5 Nov, 2021	3
4 Nov, 2021	SC 13G
3 Nov, 2021	SC 13D
3 Nov, 2021	4/A
28 Oct, 2021	4
28 Oct, 2021	4
28 Oct, 2021	4
28 Oct, 2021	4
27 Oct, 2021	SC 13G
26 Oct, 2021	4
26 Oct, 2021	8-K
26 Oct, 2021	4
26 Oct, 2021	4
26 Oct, 2021	4
26 Oct, 2021	4
26 Oct, 2021	4
26 Oct, 2021	4
26 Oct, 2021	4
25 Oct, 2021	4
25 Oct, 2021	4
25 Oct, 2021	S-8
25 Oct, 2021	4
25 Oct, 2021	4
22 Oct, 2021	SEC STAFF
22 Oct, 2021	424B4	IPO completed
22 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	EFFECT
21 Oct, 2021	CERT
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
21 Oct, 2021	3
20 Oct, 2021	S-1/A
19 Oct, 2021	CORRESP
19 Oct, 2021	CORRESP
18 Oct, 2021	S-1/A
18 Oct, 2021	8-A12B
18 Oct, 2021	CORRESP
13 Oct, 2021	UPLOAD
1 Oct, 2021	CORRESP
1 Oct, 2021	S-1
23 Sep, 2021	UPLOAD
14 Sep, 2021	DRSLTR
14 Sep, 2021	DRS/A
25 Jun, 2021	SEC STAFF
21 Jun, 2021	UPLOAD
24 May, 2021	DRS
26 Feb, 2021	D
21 Jan, 2021	D

Last update:2025-03-06 13:08:55.971943

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.